Literature DB >> 20561509

Treatment with cannabidiol reverses oxidative stress parameters, cognitive impairment and mortality in rats submitted to sepsis by cecal ligation and puncture.

Omar J Cassol1, Clarissa M Comim, Bruno R Silva, Fernanda V Hermani, Larissa S Constantino, Francine Felisberto, Fabricia Petronilho, Jaime Eduardo C Hallak, Bruno S De Martinis, Antonio W Zuardi, José A S Crippa, João Quevedo, Felipe Dal-Pizzol.   

Abstract

Oxidative stress plays an important role in the development of cognitive impairment in sepsis. Here we assess the effects of acute and extended administration of cannabidiol (CBD) on oxidative stress parameters in peripheral organs and in the brain, cognitive impairment, and mortality in rats submitted to sepsis by cecal ligation and perforation (CLP). To this aim, male Wistar rats underwent either sham operation or CLP. Rats subjected to CLP were treated by intraperitoneal injection with "basic support" and CBD (at 2.5, 5, or 10mg/kg once or daily for 9days after CLP) or vehicle. Six hours after CLP (early times), the rats were killed and samples from lung, liver, kidney, heart, spleen, and brain (hippocampus, striatum, and cortex) were obtained and assayed for thiobarbituric acid reactive species (TBARS) formation and protein carbonyls. On the 10th day (late times), the rats were submitted to the inhibitory avoidance task. After the test, the animals were killed and samples from lung, liver, kidney, heart, spleen, and brain (hippocampus) were obtained and assayed for TBARS formation and protein carbonyls. The acute and extended administration of CBD at different doses reduced TBARS and carbonyl levels in some organs and had no effects in others, ameliorated cognitive impairment, and significantly reduced mortality in rats submitted to CLP. Our data provide the first experimental demonstration that CBD reduces the consequences of sepsis induced by CLP in rats, by decreasing oxidative stress in peripheral organs and in the brain, improving impaired cognitive function, and decreasing mortality. Copyright 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20561509     DOI: 10.1016/j.brainres.2010.06.023

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  21 in total

1.  Memory-rescuing effects of cannabidiol in an animal model of cognitive impairment relevant to neurodegenerative disorders.

Authors:  Elen V Fagherazzi; Vanessa A Garcia; Natasha Maurmann; Thielly Bervanger; Luis H Halmenschlager; Stefano B Busato; Jaime E Hallak; Antônio W Zuardi; José A Crippa; Nadja Schröder
Journal:  Psychopharmacology (Berl)       Date:  2011-08-26       Impact factor: 4.530

2.  Improved Social Interaction, Recognition and Working Memory with Cannabidiol Treatment in a Prenatal Infection (poly I:C) Rat Model.

Authors:  Ashleigh L Osborne; Nadia Solowij; Ilijana Babic; Xu-Feng Huang; Katrina Weston-Green
Journal:  Neuropsychopharmacology       Date:  2017-02-23       Impact factor: 7.853

3.  Vitamin A and amygdala: functional and morphological consequences.

Authors:  Lenka Tomášová; Natália Hvizdošová; Adriana Boleková; Beňadik Smajda; Darina Kluchová
Journal:  Neurol Sci       Date:  2014-04-29       Impact factor: 3.307

4.  Cannabidiol Exposure During Neuronal Differentiation Sensitizes Cells Against Redox-Active Neurotoxins.

Authors:  Patrícia Schönhofen; Liana M de Medeiros; Ivi Juliana Bristot; Fernanda M Lopes; Marco A De Bastiani; Flávio Kapczinski; José Alexandre S Crippa; Mauro Antônio A Castro; Richard B Parsons; Fábio Klamt
Journal:  Mol Neurobiol       Date:  2014-08-10       Impact factor: 5.590

Review 5.  Early Phase in the Development of Cannabidiol as a Treatment for Addiction: Opioid Relapse Takes Initial Center Stage.

Authors:  Yasmin L Hurd; Michelle Yoon; Alex F Manini; Stephanie Hernandez; Ruben Olmedo; Maria Ostman; Didier Jutras-Aswad
Journal:  Neurotherapeutics       Date:  2015-10       Impact factor: 7.620

Review 6.  Promising cannabinoid-based therapies for Parkinson's disease: motor symptoms to neuroprotection.

Authors:  Sandeep Vasant More; Dong-Kug Choi
Journal:  Mol Neurodegener       Date:  2015-04-08       Impact factor: 14.195

7.  Cannabidiol Prevents Motor and Cognitive Impairments Induced by Reserpine in Rats.

Authors:  Fernanda F Peres; Raquel Levin; Mayra A Suiama; Mariana C Diana; Douglas A Gouvêa; Valéria Almeida; Camila M Santos; Lisandro Lungato; Antônio W Zuardi; Jaime E C Hallak; José A Crippa; D'Almeida Vânia; Regina H Silva; Vanessa C Abílio
Journal:  Front Pharmacol       Date:  2016-09-28       Impact factor: 5.810

8.  5-HT Drives Mortality in Sepsis Induced by Cecal Ligation and Puncture in Mice.

Authors:  Jingyao Zhang; Jianbin Bi; Sushun Liu; Qing Pang; Ruiyao Zhang; Shun Wang; Chang Liu
Journal:  Mediators Inflamm       Date:  2017-06-13       Impact factor: 4.711

9.  Cannabinoid modulation of neuroinflammatory disorders.

Authors:  Viviane M Saito; Rafael M Rezende; Antonio L Teixeira
Journal:  Curr Neuropharmacol       Date:  2012-06       Impact factor: 7.363

10.  Evaluation of the role of the cannabidiol system in an animal model of ischemia/reperfusion kidney injury.

Authors:  Rodrigo Zon Soares; Francieli Vuolo; Dhébora Mozena Dall'Igna; Monique Michels; José Alexandre de Souza Crippa; Jaime Eduardo Cecílio Hallak; Antonio Waldo Zuardi; Felipe Dal-Pizzol
Journal:  Rev Bras Ter Intensiva       Date:  2015 Oct-Dec
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.